Holds one active US DMF for olaparib, filing since 2024. Its GMP is recognised in 3 markets.
Holds one active US DMF for olaparib, filing since 2023. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for olaparib, filing since 2023. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for olaparib, filing since 2016.
Holds 2 active US DMFs for olaparib, filing since 2024.
This page filters the worldwide Olaparib manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for olaparib and what filings they hold.
Chat with Fred, your AI analyst